Dr. Vincenzo Di Marzo presented "Effects of Krill Oil Supplementation on the Endocannabinoid System" at the 19th Annual World Congress on Anti-Aging and Aesthetic Medicine (A4M) in Orlando, FL on Thursday, April 7, 2011. The A4M conference brings together the world's leading anti-aging experts to discuss functional and preventative medicine and bio-medical technologies.
The endocannabinoid (EC) system is comprised of a group of lipids (fats) and receptors that act within the nervous system to help modulate a number of physiological processes including appetite and mood. Obese persons have elevated levels of plasma ECs compared to healthy weight individuals. In one recent human study, healthy weight, overweight, and obese subjects were given two grams of krill oil, fish oil, or olive oil per day for four weeks. The findings demonstrated for the first time that when given in the form of krill oil a relatively low dose of phospholipid omega-3 fatty acids have beneficial effects on EC levels in obese persons.
These conclusions are especially interesting as they confirm previous outcomes with krill oil in obese animals.
A research team at the University of Salento, Lecce, Italy, has recently published a study of the the effects of krill oil on the lipid metabolism in rats. The animals were treated for 6 weeks with diets containing 2.5% krill oil or 2.5% fish oil, or a control diet without supplementation of omega-3 fatty acids. The study revealed fat-lowering effects from the omega-3 supplements, confirming that the phospholipids omega-3 fatty acids found in krill oil are effective in reducing liver triglyceride and cholesterol levels. Krill oil reduced liver triglycerides by 20% compared to 10% in the fish oil group, whereas cholesterol levels were decreased by 33% (krill oil) and 21% (fish oil).
According to Nils Hoem, PhD, Chief Scientist at Aker BioMarine, "Changes in endocannabinoid levels may be an important factor involved in potential long-term health issues, including metabolic syndrome. It is important to note that the study suggests that phospholipid form of omega-3 fatty acids found in krill oil was responsible for the beneficial effects observed."
Aker BioMarine is the only krill ingredient marketer that is primary in its supply.
Aker's proprietary Eco-Harvesting(TM) technology and on-board processing result in the unique composition of Superba(TM) Krill Oil and provide full traceability from sea to shelf. The Marine Stewardship Council (MSC) has granted MSC Certification to Aker's fisheries, an exclusive distinction that no other krill fishery has earned.
As part of an established commitment to substantiating krill's health benefits, Aker continues to sponsor in vitro, in vivo, and human clinical trials with phospholipids EPA & DHA from krill oil, consistently demonstrating a higher uptake of phospholipids omega-3 fatty acids, improved blood lipid profiles, and increased uptake of DHA in brain tissue compared to other omega-3 fatty acid sources.
About SuperbaTM Krill Oil
SuperbaTM Krill Oil is a pure, natural source of the health-promoting EPA & DHA omega-3 essential fatty acids and the naturally occurring antioxidant astaxanthin. The uniqueness of SuperbaTM Krill Oil is that the omega-3 fatty acids are provided in phospholipid form. In vitro, in vivo and human clinical research has demonstrated the safety and efficacy of SuperbaTM Krill Oil.
About Aker BioMarine
Aker BioMarine is an integrated biotechnology company dedicated to the sustainable harvesting of krill and development of krill-derived biotech products. The company supplies biomarine ingredients through an optimized value chain from raw materials to customers. Aker BioMarine's SuperbaTM Krill products are provided with 100-percent traceability from the Antarctic sea to the end user. Only Aker's krill fishery has been awarded Marine Stewardship Council (MSC) Certification.